A clinical trial to reverse age-related vision conditions using stem cell treatment could finally deliver on the promise of a major discovery in ageing and regeneration made 20 years ago, says columni ...
What happened: All 12 trial participants receiving Vertex’s VX-880 therapy began producing insulin, marking a milestone for type 1 diabetes treatment. Why it matters: VX-880 could overcome donor ...
A new light-sensitive eye injection has successfully triggered visual signals in patients with severe retinal damage.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results